Home Analyst Ratings Baird upgrades Henry Schein Inc. to an Outperform rating with a...

Baird upgrades Henry Schein Inc. [HSIC] to an Outperform rating with a $79 price target

Baird took its Henry Schein Inc. [NASDAQ:HSIC]‎‎ rating to the equivalent of Outperform from ‎Neutral, ‎and the price target to $79 from $70, ‎in a research note dated January 4, 2021. That figure ‎represents around a 18.16% premium ‎from ‎where the company’s shares closed on Thursday. ‎Other ‎analysts also revised their coverage, with Barrington Research’s analysts upgrading the shares ‎from “a ‎Mkt perform” rating to “an Outperform” rating in a research note to investors issued in ‎early ‎November. Meanwhile, Barrington Research had lowered its rating on HSIC to “Mkt perform” ‎from the ‎earlier “an Outperform”, in a research note produced for clients May 06, 2020. In addition, ‎there was ‎an upgrade from Goldman on April 07, 2020. The rater changed HSIC from “a Neutral” to “a ‎Buy”.

Get the hottest stocks to trade every day before the market ‎opens 100% ‎free. Click here now. ‎‎

Is Henry Schein Inc. [NASDAQ:HSIC] a ‎Good Buy Right Now?

It should be noted that HSIC ‎technical indicators for short, intermediate as ‎well as long term progress have placed an overall ‎average of 80% as Buy. The average signal changed ‎from 80% Buy in the last week and compares with ‎‎72% Buy in the past month. Data from Henry Schein ‎Inc.’s Trend Spotter indicated that the signals were ‎Bullish. The stock current average is 0.74 million ‎shares in the past 20 days and the short term average ‎signal indicates a 50% Buy. In the last 50 days, ‎the average trading volume was 0.98 million shares while ‎the medium term average advocated for ‎‎100% Buy. The average long-term signal stands at 100% Buy ‎and the 100-day average volume stands at ‎‎0.98 million shares.‎‎

5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!

Sponsored

HSIC Price Performance

On Wall Street, Henry Schein Inc. ‎‎[NASDAQ:HSIC] finished ‎Thursday’s session up 1.55% at $66.86. The stock went up to $66.94 at the ‎same session while its ‎lowest single day price was $65.425. In the last five days, it saw a rise of about ‎‎0.63%, Henry Schein Inc. ‎shares gained by almost 0.21% since the beginning of the year. However, the ‎share price has dropped ‎to as low as -9.64% below its one year high. On 02/19/20, the company shares ‎recorded $73.99, the ‎highest single-day price it has got to in the last 52-weeks and a 52-week low was ‎seen on 03/23/20, the ‎same year at $41.85. The company’s shares have declined by -0.39% in the past ‎year. The 50-day SMA ‎achieved is $65.69 while the 200-day SMA is $60.98. Volume dropped to 0.4 ‎million from 0.49 million in ‎the previous session.‎‎

Henry Schein Inc. [HSIC] Valuation ‎Measures

Notably, Henry Schein Inc. [HSIC] stock can be ‎classified as a good candidate in the ‎listing of underestimated low-priced Medical Distribution ‎companies to purchase soonest possible ‎with the prevailing 12-month PE ratio of 16.44. The measure ‎means the stock is exchanging at a ‎discount as compared to the 17.60x trailing earnings of the industry. ‎It can be helpful for investors to ‎consider historical price-sales ratio, more specifically, a 0.98 PS value ‎ratio is reported for the last one ‎year of reported earnings. That is higher than the industry average of ‎‎0.49 which means HSIC serve an ‎attractive investment opportunity compared to its competitors.‎‎

HSIC Stock Support And ‎Resistance Levels

On the 24-hour scale, the immediate backing is ‎perceived around 65.88 level, ‎and in case of violation of this particular level, it will cause more drop to ‎‎64.89 level. On the upper level, ‎‎67.92 is still the key resistance. The stock may increase to the ‎subsequent resistance at 67.39. The ‎Relative Strength Index (RSI) pinned on the 14-day chart is 51.15, ‎implying a neutral technical stance ‎while the MACD stands at -1.16, meaning price will decrease in the ‎next trading period. Percent R ‎indicator moved to 72.40%, implying bearish price movement. ‎Stochastic %K at 16.11% suggest selling ‎the stock.‎‎

What is the short interest in Henry Schein Inc.?

Short interest in the Henry Schein ‎Inc. stock ‎has surged, increasing by 0.48 million shares to total 5.26 million shares on Dec 14, 2020. The ‎interest ‎had seen shares on Nov 12, 2020 stand at 5.74 million, data from Yahoo Finance shows. The ‎decrease ‎of -9.13% suggests the stock saw some decreased bullish sentiment. The stock’s days to ‎cover (short ‎ratio) moved to while the shorted shares account for just 4.80% of the overall float for the ‎stock.‎‎

Henry Schein Inc.’s Biggest Shareholders: Who Owns Henry Schein Inc. [HSIC]?

Filings ‎by The ‎Vanguard Group, Inc. showed that the firm now holds a total of 15,411,479 shares or roughly ‎‎10.79% of ‎the outstanding HSIC shares. This means their shares have reduced by -1,043,154 from the ‎‎15,411,479 ‎the investor reportedly held in its prior 13-F filing. With the conclusion of the sale, ‎Generation ‎Investment Management updated stake is worth $863,870,699. Details in the latest 13F ‎filings reveal ‎that Longview Partners LLP disposed off their -3.39% stake valued at $862,029,568 while ‎BlackRock ‎Fund Advisors added theirs at $526,917,618. During the last quarter, Longview Partners LLP ‎liquidated -‎‎470,882 of its shares in Henry Schein Inc. while BlackRock Fund Advisors bought 334,320 ‎shares. The ‎SSgA Funds Management, Inc.’s holdings currently number 7,479,220 shares at ‎‎$500060649.2. ‎According to the firm’s last 13F report, Brown Brothers Harriman & Co. shares in the ‎company at filing ‎stood at 4,891,381 shares, roughly $314,564,712.‎‎

HSIC Earnings Forecast For The ‎Current Quarter

Henry Schein Inc. [HSIC] is expected to ‎report strong earnings results for the ‎quarter ending on Dec 2020. Consensus estimates give the ‎company expected revenues of $2.87B and ‎an earnings per share of $0.99 for Dec 2020. Looking ‎further ahead, the company is expected to report ‎revenue of $2.62B at an EPS of $0.86 for Mar 2021. ‎The estimates represent upside of 11.20% and ‎‎27.93% in the company’s revenue and earnings per ‎share, respectively, on a year-on-year basis.‎‎

Get the hottest stocks to trade every day before the market ‎opens 100% ‎free. Click here now. 

HSIC Earnings Estimates For The ‎Current ‎Year

For the financial year, Henry Schein Inc. [NASDAQ:HSIC] is expected to bring in ‎revenue of ‎‎$9.83B. The returns are nearly $-160.0 million lower than the company’s actual revenue ‎recorded in the ‎fiscal year 2019. In terms of EPS for the 2020, estimate put it at 2.96, lower than that of ‎FY19 by -$0.55. ‎Estimates put this year’s earnings growth at -15.70%, 28.00% for the next, and at an ‎annual 5.43% over ‎the next 5-year period. As for sales, forecasts are for a decrease of -1.50% in the ‎current fiscal year and ‎a further 11.20% over the following year.‎

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Torchlight Energy Resources Inc. (TRCH) stock surged during current market trading. Here’s to know why?

Torchlight Energy Resources Inc. (NASDAQ: TRCH) stock gained by 41.33% in the current market trading session. Torchlight Energy Resources is a vast growing oil...

The9 Ltd. (NCTY) stock declined during pre-market trading. Here’s the update

The9 Ltd. (NASDAQ: NCTY) stock plunged by 12% at the last close while the NCTY stock price fell by 7.03% during pre-market trading. The9...

The Dixie Group Inc. (DXYN) stock surged during pre-market trading given no recent news

The Dixie Group Inc. (NASDAQ: DXYN) stock gained by 11.55% in the pre-market trading session. However, there is no update available regarding this hike...

Why BancorpSouth Bank (BXS) stock plummeted on Friday?

BancorpSouth Bank (BXS) shares plummeted 9.39% in after-hours on Friday, June 18, 2021, and close the weekly business at $25.00 per share. Earlier, BXS's...

CureVac Inc. (CVAC) stock soar during pre-market trading. Here’s what you should know?

CureVac Inc. (NASDAQ: CVAC) stock declined by 38.99% at the last close while the CVAC stock price gains by 11.34% in the pre-market trading...

Anavex Inc. (AVXL) stock soars during pre-market trading. Let’s see why?

Anavex Inc. (AVXL) stock gained by 4.29% at the last close while the AVXL stock price surged by 12.38% in the pre-market trading session....

The9 Ltd. (NCTY) stock declined during pre-market trading. Here’s the update

The9 Ltd. (NASDAQ: NCTY) stock plunged by 12% at the last close while the NCTY stock price fell by 7.03% during pre-market trading. The9...

The Dixie Group Inc. (DXYN) stock surged during pre-market trading given no recent news

The Dixie Group Inc. (NASDAQ: DXYN) stock gained by 11.55% in the pre-market trading session. However, there is no update available regarding this hike...

Related News

Ocugen Inc. (NASDAQ:OCGN) stock plunged in the premarket trading session; here’s why

At last check Ocugen Inc. (OCGN) stock had plunged by-11.92% to $9.61 in premarket trading session. OCGN stock previously closed at $10.91 losing -12.79%....

KeyBanc reiterates Magna International [MGA] rating to Overweight and sets new price target at $86

KeyBanc maintained its Magna International rating to the equivalent of Overweight but changed the price target to $86.0 from $72, in a research...

Jefferies upgrades Medifast [MED] to Buy rating with a $265 price target

Jefferies took its Medifast rating to the equivalent of Buy from Hold, and the price target to $265.0 from $205, in a research...

American Eagle Outfitters [AEO] Upgraded to Outperform at RBC Capital

RBC Capital took its American Eagle Outfitters rating to the equivalent of Outperform from Sector Perform, and the price target to $30.0 from...

KeyBanc reiterates Nike [NKE] rating to Overweight and sets new price target at $180

KeyBanc maintained its Nike rating to the equivalent of Overweight but changed the price target to $180.0 from $174, in a research note...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

100% free. stop anytime no spam